RxDoctor Payments Data

Ronald Blackmore, MD

Family Medicine · Johnson City, TNNPI 1770547606

Payments from drug & device makers

$7,729in general payments, 2019–2025

Across 522 payments — averaging $14.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$721
  • AstraZeneca$711
  • GSK$688
  • Amgen$591
  • Pfizer$537
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,670100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,729 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$179,687
Medicare patients
194
Services billed
5,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$116,173
MounjaroTirzepatide53$61,555
JardianceEmpagliflozin42$46,064
OzempicSemaglutide46$45,666
FarxigaDapagliflozin Propanediol52$38,993
MyrbetriqMirabegron53$34,967
TrulicityDulaglutide18$34,844
Tresiba Flextouch U-100Insulin Degludec34$27,655
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$26,470
XareltoRivaroxaban28$21,292
Synjardy XrEmpagliflozin/Metformin Hcl12$16,272
EntrestoSacubitril/Valsartan13$11,212
LinzessLinaclotide18$11,165
Humalog Kwikpen U-100Insulin Lispro18$6,573
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$6,428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$537$116,173136 claims
Lilly USA, LLCMounjaro, Trulicity$409$96,39971 claims
Boehringer IngelheimJardiance, Synjardy Xr, Combivent Respimat$263$67,82165 claims
Novo NordiskOzempic, Novolog Mix 70-30$721$48,93358 claims
AstraZenecaFarxiga$711$38,99352 claims
Astellas Pharma US IncMyrbetriq$52$34,96753 claims
GSKTrelegy Ellipta, Incruse Ellipta$688$30,74934 claims
Johnson & JohnsonXarelto$407$21,29228 claims
AbbVieLinzess, Synthroid$1,199$13,00832 claims
NovartisEntresto$176$11,21213 claims
MerckBelsomra$31$5,32012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →